sequential therapy
DrugPatient receive Omeprazole plus amoxicillin during 5 days and then omeprazole plus clarithromycin and metronidazole during another 5 days
Other names: Omeprazole-Amoxicillin-Clarithromycin-Metronidazole
NCT Number: NCT02395458
Clinical trial to compare efficacy on eradicating Helicobacter pylori with two antibiotic strategies: sequential with amoxicillin and omeprazole 5 days and clarithromycin with metronidazole and omeprazole 5 days or omeprazole with clarithromycin and amoxicillin 14 days.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Phase 4
In patients with documented infection with Helicobacter pylori after endoscopy and biopsy, two modalities of treatment were compared, and after a control endoscopy and biopsy, eradication was assessed as well as side effects of both treatments.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Patient receive Omeprazole plus amoxicillin during 5 days and then omeprazole plus clarithromycin and metronidazole during another 5 days
Other names: Omeprazole-Amoxicillin-Clarithromycin-Metronidazole
Patient receive Omeprazole plus amoxicillin and Clarithromycin during 14 days
Other names: Omeprazole-Clarithromycin-Metronidazole
Time frame: 6 to 8 week after treatment
Helicobacter pylori in gastric biopsy
Time frame: two weeks after beginning of treatment
Nausea, vomiting, stomach ache
Coordinación de Investigación en Salud, Mexico
Other Gov
Efficacy on Helicobacter Pylori Eradication With Sequential Antibiotic Compared to Triple Therapy for 14 Days
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07340593
Bacterial Infections, Bacterial Infections and Mycoses
Vientiane, Capital, Laos
View Trial DetailsNCT02970110
Bacterial Infections, Bacterial Infections and Mycoses
Tucson, Arizona, United States
View Trial DetailsNCT03820284
Bacterial Infections, Bacterial Infections and Mycoses
Asyut, Egypt
View Trial DetailsNCT00669955
Bacterial Infections, Bacterial Infections and Mycoses
Bath, United Kingdom
View Trial Details